NIDD

This brand name is authorized in Nigeria.

Active ingredients

The drug NIDD contains one active pharmaceutical ingredient (API):

1	Glibenclamide UNII SX6K58TVWC - GLYBURIDE
	Glibenclamide, a second-generation, short half-life sulphonylurea, is a hypoglycaemic agent that reduces blood-glucose by stimulating insulin release by the pancreas. Sulphonylureas act on pancreatic beta-cells by inhibiting ATP-sensitive potassium channels.
	Read more about Glibenclamide

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-6679	Tablet	NIDD TABLETS TAB 5 mg 10 X 10	117 RNW-PP-347024 NIDD TABLETS GLIBENCLAMIDE TABLETS BP 5MG Each Tablet contains: Glibenclamide BP 5mg, Lactose (Mixing Part I) BP 20.150mg, Lactose (Mixing Part II) BP 51mg, Maize Starch BP 30.560mg, Sodium starch glycollate (Mixing) BP 2.833mg, Sodium lauryl sulfate BP 1mg, Povidone BP 3.758mg, Sodium starch glycollate (Lubrication) BP 2.883mg, Purified Talc BP 0.950mg, Colloidal anhydrous silica BP 1.4mg, Magnesium stearate BP 0.475mg. Apr-79 Drugs Imported Products 10x10 Prescription Only Medicine (POM) 9/25/2023 UNIQUE PHARMACEUTICALS LIMITED, KM 38, ABEOKUTA ROAD, VEEPEE INDUSTRIAL AVENUE, SANGO-OTA,OGUN STATE. 8097421000 mail@uniquepharm.com FOURRTS(INDIA) LABORAORIES PVT. LIMITED, VANDALUR ROAD, KELAMBAKKAM-603 103, TAMIL NADU, INDIA, India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BB01	Glibenclamide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-6679